CIK 0001770787
- Large accelerated filer
10x Genomics, Inc.
Sign in to watch- Ticker
- TXG
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455614458
- Phone
- +1 925-401-7300
- Business address
- 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,605,538
- in 10 filings, $6.3M under 10b5-1 plans
Net −$12,605,538. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-07 | Saxonov Serge Chief Executive Officer | Sale | −700 | $184.49 | $129K | 912,768 |
| 2021-09-07 | Saxonov Serge Chief Executive Officer | Sale | −1,200 | $185.50 | $223K | 911,568 |
| 2021-09-07 | Saxonov Serge Chief Executive Officer | Sale | −2,702 | $186.74 | $505K | 908,866 |
| 2021-09-07 | Saxonov Serge Chief Executive Officer | Sale | −2,025 | $187.45 | $380K | 906,841 |
| 2021-09-07 | Saxonov Serge Chief Executive Officer | Sale | −1,414 | $188.51 | $267K | 905,427 |
| 2021-09-07 | Saxonov Serge Chief Executive Officer | Sale | −2,800 | $189.81 | $531K | 902,627 |
| 2021-09-07 | Saxonov Serge Chief Executive Officer | Sale | −3,759 | $190.44 | $716K | 898,868 |
| 2021-09-07 | Saxonov Serge Chief Executive Officer | Sale | −400 | $191.13 | $76K | 898,468 |
| 2021-09-07 | Saxonov Serge Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −5,209 | 68,948 | ||
| 2021-09-07 | Saxonov Serge Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −9,791 | 58,130 | ||
| 2021-09-01 | STUELPNAGEL JOHN R Director | Sale | −300 | $175.36 | $53K | 381,316 |
| 2021-09-01 | STUELPNAGEL JOHN R Director | Sale | −1,000 | $176.36 | $176K | 380,316 |
| 2021-09-01 | STUELPNAGEL JOHN R Director | Sale | −2,300 | $177.62 | $409K | 378,016 |
| 2021-09-01 | STUELPNAGEL JOHN R Director | Sale | −1,104 | $178.34 | $197K | 376,912 |
| 2021-09-01 | STUELPNAGEL JOHN R Director | Sale | −296 | $179.15 | $53K | 376,616 |
| 2021-09-01 | McAnear Justin J. Chief Financial Officer | Exercise or conversion | +10,000 | $5.04 | $50K | 49,100 |
| 2021-09-01 | McAnear Justin J. Chief Financial Officer | Sale | −374 | $174.87 | $65K | 48,726 |
| 2021-09-01 | McAnear Justin J. Chief Financial Officer | Sale | −1,139 | $175.95 | $200K | 47,587 |
| 2021-09-01 | McAnear Justin J. Chief Financial Officer | Sale | −2,200 | $177.00 | $389K | 45,387 |
| 2021-09-01 | McAnear Justin J. Chief Financial Officer | Sale | −4,747 | $177.87 | $844K | 40,640 |
Page 26 of 57 · 1,128 trades